We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Acadia Pharmaceuticals
ACAD
$5.04B
| $6.41M | 0.01% |
132,211
-30,324
| -19% | -$1.46M |
|
1052
Voya Financial
VOYA
$9.19B
| $6.4M | 0.01% |
137,165
-36,493
| -21% | -$1.62M |
|
|
RDFN
1053
DELISTED
Redfin
RDFN
| $6.39M | 0.01% |
152,363
+28,854
| +23% | +$760K |
|
1054
US Physical Therapy
USPH
$1.22B
| $6.37M | 0.01% |
78,592
-3,037
| -4% | -$222K |
|
1055
AutoNation
AN
$6.92B
| $6.36M | 0.01% |
169,282
+7,947
| +5% | +$288K |
|
1056
Monro
MNRO
$398M
| $6.36M | 0.01% |
115,771
+2,246
| +2% | +$120K |
|
1057
Bunge Global
BG
$20.8B
| $6.35M | 0.01% |
154,398
-56,457
| -27% | -$2.19M |
|
1058
FNB Corp
FNB
$6.75B
| $6.35M | 0.01% |
846,471
+30,155
| +4% | +$227K |
|
|
BERY
1059
DELISTED
Berry Global Group, Inc.
BERY
| $6.35M | 0.01% |
156,003
+7,986
| +5% | +$300K |
|
1060
Boyd Gaming
BYD
$6.06B
| $6.32M | 0.01% |
302,452
+45,105
| +18% | +$823K |
|
1061
Radian Group
RDN
$4.91B
| $6.28M | 0.01% |
405,028
+16,491
| +4% | +$244K |
|
1062
American Eagle Outfitters
AEO
$3.01B
| $6.28M | 0.01% |
575,754
+91,021
| +19% | +$861K |
|
1063
Cannae Holdings
CNNE
$651M
| $6.27M | 0.01% |
152,651
+22,296
| +17% | +$763K |
|
1064
Bath & Body Works
BBWI
$4.1B
| $6.27M | 0.01% |
517,797
-69,686
| -12% | -$777K |
|
|
NVRO
1065
DELISTED
NEVRO CORP.
NVRO
| $6.25M | 0.01% |
52,276
+8,819
| +20% | +$1.05M |
|
1066
Simmons First National
SFNC
$3.39B
| $6.24M | 0.01% |
364,886
-14,005
| -4% | -$240K |
|
1067
International Bancshares
IBOC
$4.57B
| $6.24M | 0.01% |
194,899
+3,460
| +2% | +$99.5K |
|
1068
BlackLine
BL
$1.72B
| $6.23M | 0.01% |
75,103
+16,065
| +27% | +$1.07M |
|
1069
Jack in the Box
JACK
$336M
| $6.22M | 0.01% |
83,925
-3,994
| -5% | -$246K |
|
1070
Q2 Holdings
QTWO
$3.92B
| $6.21M | 0.01% |
72,395
+14,059
| +24% | +$1.08M |
|
|
WMGI
1071
DELISTED
Wright Medical Group Inc
WMGI
| $6.2M | 0.01% |
208,584
+20,371
| +11% | +$596K |
|
|
FOLD
1072
DELISTED
Amicus Therapeutics
FOLD
| $6.2M | 0.01% |
410,896
+38,709
| +10% | +$472K |
|
1073
Unum
UNM
$14.3B
| $6.15M | 0.01% |
370,578
-55,245
| -13% | -$872K |
|
|
LSXMK
1074
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $6.14M | 0.01% |
230,276
+37,033
| +19% | +$953K |
|
1075
Dana Inc
DAN
$3.06B
| $6.14M | 0.01% |
503,531
+14,904
| +3% | +$162K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.